Cargando…
Aryl hydrocarbon receptor agonist indigo protects against obesity-related insulin resistance through modulation of intestinal and metabolic tissue immunity
BACKGROUND/OBJECTIVES: Low-grade chronic inflammation in visceral adipose tissue and the intestines are important drivers of obesity associated insulin resistance. Bioactive compounds derived from plants are an important source of potential novel therapies for the treatment of chronic diseases. In s...
Autores principales: | Lin, Yi-Hsuan, Luck, Helen, Khan, Saad, Schneeberger, Pierre H. H., Tsai, Sue, Clemente-Casares, Xavier, Lei, Helena, Leu, Yann-Lii, Chan, Yi Tao, Chen, Hsing-Yu, Yang, Sien-Hung, Coburn, Bryan, Winer, Shawn, Winer, Daniel A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892742/ https://www.ncbi.nlm.nih.gov/pubmed/30944419 http://dx.doi.org/10.1038/s41366-019-0340-1 |
Ejemplares similares
-
An In Vitro Study of the Antimicrobial Effects of Indigo Naturalis Prepared from Strobilanthes formosanus Moore
por: Chiang, Yin-Ru, et al.
Publicado: (2013) -
Detection of aryl hydrocarbon receptor agonists in human samples
por: Rothhammer, Veit, et al.
Publicado: (2018) -
The Anti-Inflammatory Drug Leflunomide Is an Agonist of the Aryl Hydrocarbon Receptor
por: O'Donnell, Edmond F., et al.
Publicado: (2010) -
Dynamic regulation of serum aryl hydrocarbon receptor agonists in MS
por: Rothhammer, Veit, et al.
Publicado: (2017) -
Emerging concepts in intestinal immune control of obesity-related metabolic disease
por: Khan, Saad, et al.
Publicado: (2021)